SCHEMBL5072289

SCHEMBL5072289

CCCCN(Cc1cccc(OC)c1)Cc1c(-c2ccc(F)cc2)nc(-c2ccccc2)n1CCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.42
C5AR1 P21730 1/20 0.41
CALM1 P0DP23 1/20 0.41
CAMKK2 Q96RR4 1/20 0.41
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LMNA P02545 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
USP2 O75604 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
CRHR1 P34998 2/20 0.37
ATP4A P20648 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5135705 0.95 CALM1 (0.45) C5AR1CALM1CAMKK2TLR7CRHR1
SCHEMBL5170566 0.94 CALM1 (0.43) C5AR1CALM1CAMKK2ALDH1A1HSD17B10
SCHEMBL5134931 0.92 CALM1 (0.44) C5AR1CALM1CAMKK2CYP3A4ALDH1A1
SCHEMBL5137571 0.92 POLB (0.42) C5AR1CALM1CAMKK2CYP1A2CYP3A4
SCHEMBL5074293 0.91 CALM1 (0.45) C5AR1CALM1CAMKK2CYP1A2CYP3A4
SCHEMBL5137491 0.91 CALM1 (0.45) C5AR1CALM1CAMKK2CYP1A2CYP3A4
SCHEMBL5135433 0.89 C5AR1 (0.46) C5AR1CALM1CAMKK2CYP1A2CYP3A4
SCHEMBL5138064 0.89 C5AR1 (0.43) C5AR1CYP3A4ALDH1A1HSD17B10CRHR1
SCHEMBL5135383 0.89 C5AR1 (0.45) C5AR1CALM1CAMKK2CYP1A2CYP3A4
SCHEMBL5136877 0.88 C5AR1 (0.43) ABCB1C5AR1ALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed